BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 20363024)

  • 1. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
    Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
    Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
    J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
    Sadowski MJ; Pankiewicz J; Scholtzova H; Mehta PD; Prelli F; Quartermain D; Wisniewski T
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18787-92. PubMed ID: 17116874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty.
    Durairajan SS; Yuan Q; Xie L; Chan WS; Kum WF; Koo I; Liu C; Song Y; Huang JD; Klein WL; Li M
    Neurochem Int; 2008; 52(4-5):741-50. PubMed ID: 17964692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of apoE in complexes with Alzheimer's amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids.
    Lewkowicz E; Nakamura MN; Rynkiewicz MJ; Gursky O
    Cell Mol Life Sci; 2023 Nov; 80(12):376. PubMed ID: 38010414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid β peptide.
    Liu J; Liu Z; Zhang Y; Yin F
    Indian J Med Res; 2015 Aug; 142(2):190-5. PubMed ID: 26354216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
    Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
    J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
    Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
    Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Aβ-derived peptide fragments on fibrillogenesis of Aβ.
    Abedin F; Kandel N; Tatulian SA
    Sci Rep; 2021 Sep; 11(1):19262. PubMed ID: 34584131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β.
    Ghosh S; Sil TB; Dolai S; Garai K
    FEBS J; 2019 Dec; 286(23):4737-4753. PubMed ID: 31287614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol ε-viniferin glucoside: implications in Alzheimer's disease.
    Richard T; Papastamoulis Y; Waffo-Teguo P; Monti JP
    Biochim Biophys Acta; 2013 Nov; 1830(11):5068-74. PubMed ID: 23830862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitration of Y10 in Aβ1-40: is it a compensatory reaction against oxidative/nitrative stress and Aβ aggregation?
    Zhao J; Wang P; Li H; Gao Z
    Chem Res Toxicol; 2015 Mar; 28(3):401-7. PubMed ID: 25387246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells.
    Yamauchi K; Tozuka M; Hidaka H; Nakabayashi T; Sugano M; Kondo Y; Nakagawara A; Katsuyama T
    J Neurosci Res; 2000 Nov; 62(4):608-14. PubMed ID: 11070505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin inhibits A beta 40 fibril formation promoted by apolipoprotein E4 in vitro.
    Monji A; Tashiro K; Yoshida I; Hayashi Y; Tashiro N
    Brain Res; 1998 Jun; 796(1-2):171-5. PubMed ID: 9689467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner.
    Folin M; Baiguera S; Guidolin D; Di Liddo R; Grandi C; De Carlo E; Nussdorfer GG; Parnigotto PP
    Int J Mol Med; 2006 May; 17(5):821-6. PubMed ID: 16596266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitration of Tyrosine Residue Y10 of Aβ
    Zhao J; Wu J; Yang Z; Li H; Gao Z
    Chem Res Toxicol; 2017 Apr; 30(4):1085-1092. PubMed ID: 28272880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology.
    Liu S; Breitbart A; Sun Y; Mehta PD; Boutajangout A; Scholtzova H; Wisniewski T
    J Neurochem; 2014 Feb; 128(4):577-91. PubMed ID: 24117759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidylcholine increases the neurotoxicity of Alzheimer's amyloid β1-42 peptide: role of oligomer formation.
    Sheikh AM; Michikawa M; Kim SU; Nagai A
    Neuroscience; 2015 Apr; 292():159-69. PubMed ID: 25727637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.